Successful treatment of pyoderma gangrenosum with intravenous immunoglobulins during pregnancy.
BACKGROUND
Pyoderma gangrenosum is a rare ulcerative skin disease usually starting with a pustular lesion that rapidly progresses to painful ulcers with undermined violaceous borders. Numerous associated disorders have been described, including inflammatory bowel disease, rheumatologic or hematologic disorders, chronic active hepatitis, and malignancies. The occurrence of pyoderma gangrenosum during pregnancy is uncommon.


OBJECTIVE
We report a case of a patient with an aggravation of preknown pyoderma gangrenosum during pregnancy who was successfully treated with intravenous immunoglobulins.


CONCLUSIONS
Administration of immunoglobulins represents a safe and effective treatment option for this subset of patients, as demonstrated in the present case.
Department of Dermatology, University Hospital Erlangen, Germany. Cornelia.Erfurt.Berge@uk-erlangen.de
Cornelia
C
Erfurt-Berge
Christine
C
Herbst
Gerold
G
Schuler
Juergen
J
Bauerschmitz
D000328:Adult; D005260:Female; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy*; D017511:Pyoderma Gangrenosum / Q000188:drug therapy*
D016756:Immunoglobulins, Intravenous